Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project-Reference-Cited by-同舟云学术

Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project

Published:2013-04-04 Issue:5 Volume:36 Page:335-347
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

McKoy June M.,Fisher Matthew J.,Courtney D. Mark,Raisch Dennis W.,Edwards Beatrice J.,Scheetz Marc H.,Belknap Steven M.,Trifilio Steven M.,Samaras Athena T.,Liebling Dustin B.,Nardone Beatrice,Tulas Katrina Marie,West Dennis P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/s40264-013-0042-x.pdf

Reference54 articles.

1. Institute of Medicine. The future of drug safety: promoting and protecting the health of the public. Washington, DC: National Academies Press; 2006.

2. Miwa LK, Jone JK, Mann RD. Identifying resources for assessing use and effects of pharmaceuticals and other medical products in the European Community. In: Fracchia GN, editor. European medicines research: perspectives in pharmacotoxicology and pharmacovigilance. Amsterdam: IOS Press; 1994. p. 391–407.

3. Shimizu N, Tanaka Y, Jones JK, Taylor D, editors. Improving drug safety: the assessment, management and communication of the therapeutic benefits and risks of pharmaceutical products, the official proceedings for the RAD-AR symposium. Tokyo: Pharma International Inc.; 1989.

4. Bennett CL, Nebeker JR, Lyons EA, et al. The Research on Adverse Drug Events and Reports (RADAR) project. JAMA. 2005;293(17):2131–40.

5. Bennett CL, Nebeker JR, Yarnold PR, et al. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med. 2007;167:1041–9.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of anticancer therapy-related dermatologic adverse events: Insights from Food and Drug Administration's Adverse Event Reporting System dataset;Journal of the American Academy of Dermatology;2024-07

2. Evaluating Postmarket Vaccine Safety—Time to Consolidate This Mission at a Single Agency;JAMA Health Forum;2021-04-29

3. Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program;Journal of the American Academy of Dermatology;2020-09

4. Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program;Journal of the American Academy of Dermatology;2019-03

5. Malignant melanoma associated with chronic once-daily aspirin exposure in males: A large, single-center, urban, US patient population cohort study from the “Research on Adverse Drug events And Report” (RADAR) project;Journal of the American Academy of Dermatology;2018-10